TickerFactsScreenerDevelopers

VYNE Therapeutics Inc. (VYNE) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2015: -$4.18M2016: -$2.27M2017: -$28.22M2018: -$68.66M2019: -$73.39M2020: -$137.08M2021: -$56.37M2022: -$29.20M2023: -$25.34M2024: -$33.97M2025: -$33.12M-$33.12M
2015Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$33.12M+2.5%
2024-$33.97M-34.1%
2023-$25.34M+13.2%
2022-$29.20M+48.2%
2021-$56.37M+58.9%
2020-$137.08M-86.8%
2019-$73.39M-6.9%
2018-$68.66M-143.3%
2017-$28.22M-1146.0%
2016-$2.27M+45.9%
2015-$4.18M—